Family Medicine Doctors in Limerick, ME Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 David W Galbraith, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 44 Elm St, Limerick, ME 04048 Phone: 207-793-9586 Fax: 207-793-9587 |
 Kathryn Galbraith, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 44 Elm St, Limerick, ME 04048 Phone: 207-793-9586 Fax: 207-793-9587 |
News Archive
Indiscriminate expensive imaging has little clinical benefit in patients requiring epidural steroid injections
Johns Hopkins-led research suggests that routine MRI imaging does nothing to improve the treatment of patients who need injections of steroids into their spinal columns to relieve pain. Moreover, MRI plays only a small role in a doctor's decision to give these epidural steroid injections (ESIs), the most common procedure performed at pain clinics in the United States.
Study evaluates effects of psychological program to improve teachers' mental health
With respect to the Symptoms Check List-27, the values of the GSI (Global Severity Index) and of 3 subscales (those for depressive, dysthymic and mistrust symptoms), compared with the control group, improved significantly upon participation in the group program.
Chemotherapy-induced nausea and vomiting most common distressing symptoms in majority of cancer patients
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc., found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live.
SARS-CoV-2 nucleocapsid antigen as a possible COVID-19 severity marker
French researchers used a highly sensitive and specific nucleocapsid-Ag assay to explore the relationship between N-Ag in urine during COVID-19 and the severity of the disease in hospitalized patients.
Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer
Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.
› Verified 3 days ago